Speech Perception Training: Advanced Scoring and Feedback Methods
Launched by SEEHEAR LLC · Aug 18, 2021
Trial Information
Current as of July 21, 2025
Unknown status
Keywords
ClinConnect Summary
It is hypothesized that training that improves lipreading in older adults can carry over to untrained lipreading materials and to audiovisual speech recognition in noise. Participants receive pre- and post-training tests of speech recognition with visual-only, auditory-only, and audiovisual spoken sentences and isolated words. During pre- and post-training tests, they carry out forced choice identification of lipread consonants. Participants who are assigned to a training arm train on lipreading isolated sentences (Aim 1) or on learning via lipreading sets of isolated nonsense words (Aim 2)...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Must have Mild to severe hearing loss
- • Native speaker of American English
- • Access to computer and the ability to use it for the testing, training, and teleconferencing
- • computer display \>= 10 inches diagonal
- Exclusion Criteria:
- • Internet too slow for streaming
- • History of brain trauma or learning disability
- • Poor (corrected) vision
About Seehear Llc
SeeHear LLC is a pioneering clinical trial sponsor dedicated to advancing innovative solutions in the field of auditory and visual health. With a strong commitment to enhancing patient outcomes, SeeHear LLC collaborates with leading researchers and healthcare professionals to conduct rigorous clinical studies that evaluate the safety and efficacy of cutting-edge therapies and technologies. By leveraging a patient-centered approach and utilizing state-of-the-art methodologies, the organization seeks to contribute meaningful insights to the medical community and improve the quality of life for individuals with sensory impairments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Washington, District Of Columbia, United States
Washington, Virginia, United States
Patients applied
Trial Officials
Lynne E Bernstein, Ph.D.
Study Director
George Washington University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials